Indications : התוויות

4.1 Therapeutic indications
AmpiSulVenir is antibiotic indicated for the treatment of bacterial infections caused by susceptible beta- lactamase producing strains of microorganisms, in the following conditions: 1. Skin and Skin Structure Infections
2. Intra- Abdominal Infections
3. Gynecological Infections
Skin and Skin Structure Infections caused by beta-lactamase producing strains of Staphylococcus aureus, Escherichia coli,* Klebsiella spp.* (including K. pneumoniae*), Proteus mirabilis,* Bacteroides fragilis,* Enterobacter spp.,* and Acinetobacter calcoaceticus.*
NOTE: For information on use in pediatric patients see PRECAUTIONS–Pediatric Use and Clinical Studies sections.


Intra-Abdominal Infections caused by beta-lactamase producing strains of Escherichia coli, Klebsiella spp.
(including K. pneumoniae*), Bacteroides spp. (including B. fragilis), and Enterobacter spp.* 

Gynecological Infections caused by beta-lactamase producing strains of Escherichia coli,* and Bacteroides spp.* (including B. fragilis*).


While AmpiSulVenir is indicated only for the conditions listed above, infections caused by ampicillin- susceptible organisms are also amenable to treatment with AmpiSulVenir due to its ampicillin content.
Therefore, mixed infections caused by ampicillin-susceptible organisms and beta-lactamase producing organisms susceptible to AmpiSulVenir should not require the addition of another antibiotic 
Consideration should be given to official guidance on the appropriate use of antibacterial agents.